This message contains images. If you don't see images, click here to view.
Advertise in this news brief.



Text version   RSS   Subscribe   Unsubscribe   Archive   Media Kit February 05, 2015
Advertisement
   NAMCP Medical Directors Institute   AAMCN    AAIHDS    Conferences    JMCM    Contact Us  

We wanted you to be aware that FDA-approved Hysingla™ ER (hydrocodone bitartrate) extended-release tablets CII has commercially launched in the U.S. Please click here to view the press release.

Click here for a CME/CEU activity on Improving Treatment of Atrial Fibrillation and Stoke

Otezla® (apremilast) is approved for the treatment of patients with moderate to severe plaque psoriasis who are candidates for phototherapy or systemic therapy. Please click here for more information.

Click here to view our Complimentary Online CME/CEU Webcasts

 

Register today: 2015 Spring Managed Care Forum

Register today for the 2015 Spring Forum being held April 23-24, 2015 at Disney's Yacht & Beach Club. Click here to visit the conference website.
   Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE  




GENOMICS


US to collect genetic data to hone care
The New York Times
Saying that “the possibilities are boundless,” President Barack Obama announced a major biomedical research initiative, including plans to collect genetic data on one million Americans so scientists could develop drugs and treatments tailored to the characteristics of individual patients. Dr. Francis S. Collins, the director of the National Institutes of Health, said the studies would help doctors decide which treatments would work best for which patients.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Supercomputing reveals the genetic code of cancer
Medical Xpress
Cancer researchers must use one of the world's fastest computers to detect which versions of genes are only found in cancer cells. Every form of cancer, even every tumor, has its own distinct variants. "This charting may help tailor the treatment to each patient," says Associate Professor Rolf Skotheim, who is affiliated with the Centre for Cancer Biomedicine and the Research Group for Biomedical Informatics at the University of Oslo, as well as the Department of Molecular Oncology at Radiumhospitalet, Oslo University Hospital.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


SPONSORED CONTENT


23andMe: Your genes may be to blame for your motion sickness
SFGate
If you're prone to nausea while riding a car or a roller coaster, your genetics may be responsible, according to a new study from 23andMe. In research published this month, the Mountain View personal genetics testing startup conducted what it said was the first genome-wide association study on motion sickness in almost 80,500 people in its database.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


BIOTECH/DIAGNOSTICS/PERSONALIZED MEDICINE


How big data opens new vistas in personalized medicine
Phys.org
"Innovations, Information, and Imaging" is the theme of the annual meeting of the American Association for the Advancement of Science (AAAS 2015), which takes place in San Jose Feb. 12-16. Along with international research partners, the Technische Universitat Munchen has organized a symposium on proteomics, a research field that will open the stage for a more personalized approach in biomedical research and therapy.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


PRODUCT SHOWCASE
  Measure, Monitor Immunoglobulin Treatment Outcomes
BioFeedback for immunoglobulin is a health outcomes reporting program that provides clinical feedback on the use of immunoglobulin in autoimmune-related disorders. Physicians and medical directors can now deploy clinical interventions when they have the greatest impact on healthcare quality and costs.

Request more information or schedule a personal introduction.
 


Hospital execs: Obama's precision medicine initiative would be 'game changing'
Boston Business Journal
Researchers and hospital executives walked away from a gathering at the White House with renewed vigor and morale after President Barack Obama announced a $215 million plan to grow cancer therapies and understanding in medicine tailored to a person's genetics.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


New initiative aims at reducing adverse effects of medications in individuals with mental illnesses
News-Medical.net
Geneticists at the University of Pittsburgh Graduate School of Public Health will provide their scientific expertise to a new initiative aimed at preventing and reducing the adverse effects of medications in people with mental illnesses. The research project will take a personalized medicine approach to managing drug therapy by analyzing each patient's genetic makeup to determine potential adverse reactions to medications.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


REGENERATIVE MEDICINE


Researchers question treatment of infertility with stem cells
Medical Xpress
New studies by Swedish researchers at institutions including the University of Gothenburg and Karolinska Institute are questioning the notion that infertility can be treated with stem cells. Whether or not infertility can be treated with stem cells has been a matter of debate for many years. The classical theory is based on the idea that the eggs a woman has are the ones she has had from birth, but there are researchers who claim that stem cell research could lead to the creation of new eggs.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Gordie Howe making dramatic recovery after stem cell therapy
USA Today
Detroit Red Wings legend Gordie Howe has made such a dramatic recovery after having stem cell therapy in December in Tijuana, Mexico, that he's heading to Saskatoon, Saskatchewan, this weekend for a dementia fundraiser involving Wayne Gretzky. The Kinsmen Arena there will be renamed the Gordie Howe Kinsman Arena.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


  FEATURED COMPANIES
What is Solesta?

What does a good day mean for your patients?

LEARN MORE
Advertise here!

To find out how to feature your company in the GBEMTI eNewsletter and other advertising opportunities, Contact Geoffrey Forneret at 469-420-2629.
MORE


EMERGING MEDICAL TECHNOLOGIES


Fitness wearables: To track or not to track
By Natalie Rodriguez
The fitness wearables market has taken off in the past few years, and fitness tech products were all the rage at CES 2015. The wearable technology market will continue to grow, but are consumers jumping on the bandwagon? Over the years, activity trackers have evolved from simple heart rate monitors and pedometers to now tracking mileage, physical activity, calorie intake, heart rate, sleep quality, body temperature, stress level and more. This begs the question: Are fitness wearables a must-have?
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


FDA: NEW TREATMENTS AND TECHNOLOGY


FDA approves an ADHD drug as the first treatment for binge-eating disorder
The Associated Press via Fox Business
Federal health regulators have approved an attention deficit disorder drug for a new use: A first-of-its kind treatment for binge-eating disorder. The Food and Drug Administration first approved Vyvanse as a once-a-day pill for attention deficit hyperactivity disorder in 2007. On Friday the agency cleared the drug for adults who compulsively overeat.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Bluebird gene therapy wins FDA's 'breakthrough' designation
The Boston Globe
Cambridge startup Bluebird Bio Inc., which is working in the field of gene therapy, said Monday that its experimental treatment for a rare blood disorder has won a “breakthrough therapy” designation from the Food and Drug Administration. The designation was created by the FDA to speed up the development and regulatory review of drug candidates that treat serious or life-threatening diseases when early clinical studies show substantial improvement over existing medicines.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


ACCOUNTABLE CARE ORGANIZATIONS


Recommendations for physician-led ACOs
Government Health IT
If you’re a primary care physician, are you a doctor or a CEO? According to a new article in the Journal of the American Medical Association, that question isn’t as off-base as it initially may seem. Penned by, among others, former ONC chief Farzad Mostashari, M.D., the piece suggests readers “consider that a typical primary care physician has approximately 2000 patients, each of whom annually accounts for about $5000 for healthcare spending.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


ACO task force sets sights on quality, sustainability
FierceHealthPayer
The Health Care Task Force, which is comprised of Aetna, Health Care Services Corporation, Blue Shield of California and BCBS of Massachusetts and several providers, has a difficult goal to acheive: Establishing a standard for value-based care.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Miss an issue of Genomics Biotech and Emerging Medical Technologies Institute eBrief? Click here to visit the archive page.


MANAGED HEALTHCARE NEWS


Survey: Patient engagement continues to face challenges
By Scott E. Rupp
In the true age of patient engagement — a topic much talked about the last two years, but one now seemingly having gained real traction — providers continue to admit that they are having trouble with meeting the mandates established for them by meaningful use stage 2 requirements. The challenges they face with engaging patients, of course, means they also run the risk of pushing away patients if they fail to meet consumers on their terms. This is a fairly standard industry sentiment and one of the primary takeaways from a recent nationwide survey.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Ebola, measles and Chris Christie's inconsistent healthcare beliefs
Forbes
New Jersey Governor and likely presidential candidate Chris Christie is responsible for the current measles outbreak in the United States. Well that is a bit of a stretch — but not by much. The governor just can’t figure out where he stands in balancing the public good against individual rights. When Ebola reached his state last October in the form of Kaci Hickox, a nurse who had treated Ebola patients in West Africa, Christie ordered her held in a plastic tent near Newark with no running water, reliable heat or any other amenities.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


12 simple ways to save money on healthcare
U.S. News & World Report
In the last few years, consumers have found themselves paying a higher percentage of their medical costs. The Affordable Care Act has given more Americans access to health insurance, but many of those plans come with high deductibles — which are also becoming more common in employer-provided plans.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


FAST FACTS
"From Jan. 1-30, 2015, 102 people from 14 states were reported to have measles. Most of these cases are part of a large, ongoing multi-state outbreak linked to an amusement park in California."


TRENDING ARTICLES
Missed last week's issue? See which articles your colleagues read most.

    Autism genomes add to disorder's mystery (Los Angeles Times)
How genes and environment conspire to trigger diabetes (LiveScience via Fox News)
Manchester researcher discover novel way to eradicate cancer stem cells (News-Medical.net)
Is Obamacare about controlling our lives? (CNN)
Obama's precision medicine initiative stirs hope, caution (Los Angeles Daily News)

Don't be left behind. Click here to see what else you missed.
 

Genomics Biotech and Emerging Medical Technologies Institute eBrief
Colby Horton, Vice President of Publishing, 469.420.2635
Download media kit

Natalie Rodriguez, Senior Content Editor, 469.420.2635   
Contribute news

This edition of the Genomics Biotech and Emerging Medical Technologies Institute eBrief was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Subscribe here — it's free!
Recent issues
Jan. 29, 2015
Jan. 22, 2015
Jan. 15, 2015
Jan. 8, 2015



7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063